Diffuse large B-cell lymphoma (DLBCL), the most frequent malignant lymphoma in adults, is characterized by constitutive NF-κB activation and consequently by a constitutive production of interleukin-6 (IL-6) and IL-10. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.